Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$737M |
| 2 |
American Tower
AMT
|
+$687M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$554M |
| 4 |
Abbott
ABT
|
+$553M |
| 5 |
SLB Ltd
SLB
|
+$449M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shopify
SHOP
|
+$1.06B |
| 2 |
Netflix
NFLX
|
+$816M |
| 3 |
Match Group
MTCH
|
+$678M |
| 4 |
NVIDIA
NVDA
|
+$611M |
| 5 |
Intuitive Surgical
ISRG
|
+$530M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.17% |
| 2 | Consumer Discretionary | 21.87% |
| 3 | Healthcare | 15.92% |
| 4 | Financials | 9.87% |
| 5 | Communication Services | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Bally's
BALY
$682M
| $11.4M | 0.01% |
577,852
-126,923
| -18% | -$3.28M |
|
377
Moody's
MCO
$82.8B
| $11.2M | 0.01% |
41,224
-1,871
| -4% | -$560K |
|
|
LPRO
378
Open Lending Corp
LPRO
| $11.1M | 0.01% |
1,088,248
+35,268
| +3% | +$472K |
|
379
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
| $10.7M | 0.01% |
237,394
-14,772
| -6% | -$715K |
|
380
Moelis & Co
MC
$4.97B
| $10.7M | 0.01% |
270,892
+6,902
| +3% | +$301K |
|
|
BKI
381
DELISTED
Black Knight, Inc. Common Stock
BKI
| $10.6M | 0.01% |
162,661
-7,042
| -4% | -$474K |
|
382
Concrete Pumping Holdings
BBCP
$490M
| $10.2M | 0.01% |
1,679,068
-20,509
| -1% | -$116K |
|
383
TC Energy
TRP
$70.2B
| $9.94M | 0.01% |
191,971
+60,390
| +46% | +$3.37M |
|
384
Ciena
CIEN
$53.4B
| $9.91M | 0.01% |
216,810
-116,510
| -35% | -$6.04M |
|
385
ACV Auctions
ACVA
$1.31B
| $9.89M | 0.01% |
1,512,252
+39,313
| +3% | +$405K |
|
|
OLK
386
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $9.88M | 0.01% |
650,091
+16,394
| +3% | +$213K |
|
|
SMAR
387
DELISTED
Smartsheet Inc.
SMAR
| $9.82M | 0.01% |
312,539
-630,512
| -67% | -$26.1M |
|
388
PENN Entertainment
PENN
$2.75B
| $9.77M | 0.01% |
321,116
+81,982
| +34% | +$2.77M |
|
389
Q2 Holdings
QTWO
$3.8B
| $9.41M | 0.01% |
244,073
+6,617
| +3% | +$322K |
|
390
Kinetik
KNTK
$3.72B
| $9.31M | 0.01% |
+272,809
| New | +$10.1M |
|
391
Arcutis Biotherapeutics
ARQT
$3.36B
| $9.27M | 0.01% |
+435,019
| New | +$8.92M |
|
392
Oneok
OKE
$57.2B
| $9.22M | 0.01% |
166,080
-181,984
| -52% | -$11.8M |
|
393
Nutrien
NTR
$33.2B
| $9.21M | 0.01% |
115,591
-26,944
| -19% | -$2.62M |
|
394
Steel Dynamics
STLD
$36B
| $9.16M | 0.01% |
138,524
-172,754
| -55% | -$13.8M |
|
395
Bilibili
BILI
$7.99B
| $9.14M | 0.01% |
356,896
-1,099,714
| -75% | -$26.4M |
|
|
NVRO
396
DELISTED
NEVRO CORP.
NVRO
| $9.09M | 0.01% |
207,438
+59,755
| +40% | +$3.29M |
|
397
Sea Limited
SE
$65.4B
| $9.08M | 0.01% |
135,850
-317,100
| -70% | -$27M |
|
398
Caterpillar
CAT
$375B
| $9.03M | 0.01% |
50,491
-29,083
| -37% | -$6.13M |
|
399
Metropolitan Bank Holding Corp
MCB
$1.15B
| $8.82M | 0.01% |
127,097
-7,892
| -6% | -$654K |
|
|
VRNT
400
DELISTED
Verint Systems
VRNT
| $8.72M | 0.01% |
+205,917
| New | +$10.3M |
|
Similar funds
Jennison Associates's Q2 2022 Portfolio in Review
As of Q2 2022, Jennison Associates held 720 positions worth $100B, down 26% from $136B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Jennison Associates withdrew a net $3.7B in Q2 2022, closing 106 positions and reducing 265 holdings. Its most notable exit was Okta, an estimated $272M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in KBR worth $40.4M.
- Jennison Associates's largest Q2 2022 buy was KBR: 834,334 shares worth $40.4M.
- Jennison Associates added most to Eli Lilly in Q2 2022, an estimated $737M increase.
- Jennison Associates's biggest Q2 2022 reduction was Shopify, cutting an estimated $1.06B.
- Jennison Associates fully exited Okta in Q2 2022, selling an estimated $272M.
- Jennison Associates's ten largest holdings make up 41% of its $100B portfolio in Q2 2022.
- Jennison Associates opened 95 new positions and closed 106 in Q2 2022.
- Jennison Associates's portfolio value fell 26% quarter-over-quarter to $100B.
Based on Jennison Associates's 13F filing for Q2 2022, filed 2 Aug 2022.